RenaissanceRe (RNR)
(Delayed Data from NYSE)
$234.67 USD
+2.81 (1.21%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $234.66 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum B VGM
RenaissanceRe (RNR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$267.27 | $350.00 | $218.00 | 15.27% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for RenaissanceRe comes to $267.27. The forecasts range from a low of $218.00 to a high of $350.00. The average price target represents an increase of 15.27% from the last closing price of $231.86.
Analyst Price Targets (11)
Broker Rating
RenaissanceRe currently has an average brokerage recommendation (ABR) of 2.15 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.15 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 46.15% and 7.69% of all recommendations. A month ago, Strong Buy made up 46.15%, while Buy represented 7.69%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.15 | 2.15 | 2.15 | 2.15 | 2.15 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/1/2024 | Cowen & Co. | Andrew S Kligerman | Hold | Hold |
7/26/2024 | Wells Fargo Securities | Elyse Greenspan | Strong Buy | Strong Buy |
7/26/2024 | Evercore Partners | David Motemaden | Strong Sell | Strong Sell |
7/9/2024 | Dowling & Partners | Kyle R Labarre | Not Available | Strong Buy |
5/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/9/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Buy | Moderate Buy |
2/5/2024 | BMO Capital Markets | Michael Zaremski | Strong Buy | Strong Buy |
2/5/2024 | UBS | Brian R Meredith | Not Available | Hold |
1/31/2024 | JMP Securities | Matthew J Carletti | Not Available | Hold |
11/22/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.15 |
ABR (Last week) | 2.15 |
# of Recs in ABR | 13 |
Average Target Price | $267.27 |
LT Growth Rate | 4.80% |
Industry | Insurance - Property and Casualty |
Industry Rank by ABR | 81 of 253 |
Current Quarter EPS Est: | 4.95 |